This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Loftus EV, Colombel J-F, Rutgeerts P, Rubin DT, Chen N, Mulani P, Chao J.Quality-of-life improvements in patients with Crohn's disease treated for 3 years with Adalimumab in an open-label extension CHARM. Digestive Disease Week 2009: 179 abstr. S1056, 30 May 2009. Available from: URL: http://www.ddw.org
Loftus EV, Rubin DT, Chen N, Mulani P, Chao J.Remission and quality of life improvements sustained with Adalimumab in anti-TNF-naive patients with crohn's disease: 3-year data from CHARM. Digestive Disease Week 2009: 180 abstr. S1062, 30 May 2009. Available from: URL: http://www.ddw.org
Schwartz D, Colombel J-F, Rutgeerts P, Feagan BG, Kamm MA, Chen N, Mulani P, Chao J.Sustained improvement in quality of life for patients with fistulizing crohn's disease treated with Adalimumab: 3-year ata from CHARM. Digestive Disease Week 2009: 180-181 abstr. S1063, 30 May 2009. Available from: URL: http://www.ddw.org
Louis E, Lofberg R, Reinisch W, Chen N, Chao J, Mulani P.Improvements in work productivity and quality of life in Adalimumab treated patients with crohn's Disease: the care trial. Digestive Disease Week 2009: 179 abstr. S1057, 30 May 2009. Available from: URL: http://www.ddw.org
Rights and permissions
About this article
Cite this article
Adalimumab works like a CHARM in Crohn's disease. Pharmacoecon. Outcomes News 582, 9–10 (2009). https://doi.org/10.2165/00151234-200905820-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00020